Ok. I'd hate to correct completely wrong statements, but here we go:How about backing up your bullshit claims with some evidence?
Europe does not have cheaper meds because the American taxpayer subsides their development. It is European government that subside the cost to the patient. Pharma companies might get away with charging US insurers more than EU Governments but that is another story.
As for European citizens being banned from paying for medical research.... must explain why charities such as Cancer Research UK receive millions each year. What a load of crap.
Oh, and by the way.. plenty of research goes on outside your isolated little bubble, even in countries with a state healthcare system and even (get this) without the motive of profit!
Critical Condition: Cheaper in Canada - ABC News
Canadians are spared higher drug prices, in large part because of price controls. The Canadian government has established a "Patented Medicine Prices Review Board" to ensure drug prices are not excessive.
The review board has established a very specific formula for drug companies wishing to sell in Canada:
Existing drugs cannot increase in price by more than the rate of inflation.
New drugs cannot cost more than similar drugs for the same illness.
^--note that that not only implies canadian drugs are cheaper without subsidies, but also that the price varies extraordinarily WITHOUT subsidies. It wouldn't make much sense to use anything other than the raw price for this calculation.And a breakthrough drug, the first of a new class of drugs, cannot cost more than the median price for the drug in other countries.
For example, the new cancer drug Campath is priced as follows: United States: $2,400 France: $760 Sweden $660 Britain $570 Italy $500 The median, or "midprice," is $660, so Canadian regulations say that's the most the drug can sell for in Canada.
:zzwhip: :zzwhip: :zzwhip:Every industrialized country has some form of price controls on patented medications, except the United States. American drug companies say price controls stifle innovation and discourage them from selling certain drugs in foreign markets.
And yes, this is the same pharma market Obama just crawled into bed with.